Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for End-Point Detection in Compression Process – V 2.0

Posted on By

Tablets: SOP for End-Point Detection in Compression Process – V 2.0

Standard Operating Procedure for End-Point Detection in Compression Process

Department Tablet
SOP No. SOP/TAB/061/2025
Supersedes SOP/TAB/061/2022
Page No. Page 1 of 7
Issue Date 15/12/2025
Effective Date 20/12/2025
Review Date 15/12/2026

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the procedure for detecting the end-point during the tablet compression process. The goal is to ensure that tablets are compressed to the correct hardness, weight, and thickness, and to determine when to stop the compression process to maintain product consistency and quality.

2. Scope

This SOP applies to the tablet compression process during tablet manufacturing. It focuses on the identification of the end-point for compression, which is based on the tablet characteristics and in-process monitoring. The SOP is applicable to all tablet manufacturing batches that require compression.

3. Responsibilities

  • Manufacturing Personnel: Responsible for monitoring the tablet compression process and detecting the end-point based on tablet characteristics such as hardness, weight, and thickness.
  • Quality Control (QC): Responsible for verifying the tablet characteristics at various intervals and confirming the end-point of compression. QC also ensures that the tablets meet the required specifications.
  • Quality Assurance (QA): Ensures that the procedure for end-point detection
follows this SOP and that any deviations from standard process parameters are documented and resolved.
  • Maintenance Personnel: Responsible for ensuring the tablet press is calibrated and in good working condition, and that all related equipment used in the compression process is functioning properly.
  • 4. Accountability

    The Production Manager is accountable for overseeing the tablet compression process, ensuring that the end-point is accurately detected, and confirming that the tablets meet the required specifications. The QA Manager is responsible for verifying compliance with the SOP and ensuring that all deviations are addressed and documented.

    5. Procedure

    5.1 Preparing for Compression

    1. Ensure that the tablet press is clean and calibrated before starting the compression process. Verify that the tablet press settings are aligned with the batch record specifications.
    2. Prepare the granules or powder blend for compression, ensuring that it meets the required specifications for flowability, particle size distribution, and moisture content.
    3. Ensure that the correct tooling (punches and dies) is installed, and confirm that the tablet press is configured for the correct tablet shape and size as per the batch record.
    4. Set the tablet press parameters, including compression force, tablet thickness, and feed rate, as specified in the batch record.

    5.2 Detecting the End-Point of Compression

    1. During the compression process, monitor the key tablet characteristics that determine when to stop the compression, including:
      • Tablet weight
      • Tablet hardness
      • Tablet thickness
    2. Monitor tablet hardness using a hardness tester or in-line measurement system at regular intervals during the compression process.
    3. Check tablet weight consistency using a balance or in-line weight measurement system at regular intervals during the compression process.
    4. Monitor tablet thickness and ensure it remains consistent according to the established parameters.
    5. Once tablets meet the predefined hardness, weight, and thickness criteria, stop the compression process to prevent over-compression, which could lead to defects or unacceptable tablet properties.

    5.3 In-Process Monitoring

    1. During the compression process, regularly sample tablets for in-process testing. Measure tablet weight, hardness, and thickness at intervals defined in the batch record (e.g., every 30 minutes or after a specified number of tablets).
    2. If any of the tablet characteristics fall outside the acceptable range, stop the compression process and investigate the cause.
    3. Adjust the compression force, feed rate, or tooling if necessary to bring the tablets back into specification.
    4. Once the tablets meet the required specifications, document the end-point detection and the settings used for compression.

    5.4 Final Verification of Tablet Quality

    1. After the compression process has been stopped, conduct a final check of the tablet characteristics to confirm that the tablets meet the established specifications.
    2. Perform tablet hardness, weight, and thickness testing on a representative sample of tablets from the batch.
    3. Verify that the tablets have a uniform appearance and do not exhibit defects such as capping, lamination, or cracking.
    4. If any tablets fail to meet the specifications, reject the batch or perform rework as necessary according to the batch record and deviation report (Annexure-2).

    5.5 Documentation and Record-Keeping

    1. Record all relevant data, including compression settings, tablet weight, hardness, thickness measurements, and any adjustments made during the process, in the batch record (Annexure-1).
    2. Document any deviations from the prescribed process in the deviation report (Annexure-2), and describe the corrective actions taken.
    3. Ensure that all records are signed, dated, and stored according to the company’s record retention policy for future audits and inspections.

    5.6 Calibration and Maintenance of Compression Equipment

    1. Ensure that the tablet press is regularly calibrated to maintain accurate tablet weight, hardness, and thickness measurements.
    2. Perform routine maintenance checks on the tablet press according to the preventive maintenance schedule to ensure optimal performance and minimize the risk of equipment malfunction.
    3. Document all calibration and maintenance activities in the equipment maintenance log (Annexure-3).

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • GMP: Good Manufacturing Practice
    • QC: Quality Control
    • QA: Quality Assurance
    • API: Active Pharmaceutical Ingredient

    7. Documents

    1. Batch Record (Annexure-1)
    2. Deviation Report (Annexure-2)
    3. Equipment Maintenance Log (Annexure-3)

    8. References

    • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
    • EU GMP Guidelines Part I – Basic Requirements for Medicinal Products
    • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Batch Record

    Batch Number Compression Force Tablet Weight Tablet Hardness Tablet Thickness End-Point Detection Notes
    Batch 001 10 kN 500 mg 7 kg 4 mm Compression stopped after achieving target hardness and weight

    Annexure-2: Deviation Report

    Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
    18/12/2025 Batch 002 Tablet hardness outside target range Adjusted compression force John Doe

    Annexure-3: Equipment Maintenance Log

    Maintenance Date Equipment Component Maintenance Performed Performed By Comments
    10/12/2025 Tablet Compression Machine Calibration and Tooling Inspection Jane Smith Calibration verified, tooling in good condition

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP Creation QA Head
    01/02/2025 2.0 Updated End-Point Detection Parameters Optimized Process QA Head
    See also  Tablets: SOP for pH Stability Testing for Enteric-Coated Tablets - V 2.0
    Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

    Post navigation

    Previous Post: SOP for Use of Dissolution Testing in Screening Formulations
    Next Post: Ointments: SOP for Testing Ointment Viscosity – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version